222
Y.-G. Hu, J. Xu, H.-T. Gao, and Z. Ma
Vol 47
C22H22FN3O2 (379.4): C, 69.64; H, 5.84; N, 11.07; Found: C,
69.71; H, 5.92; N, 11.00.
CH3), 4.50 (d, J ¼ 7.2, 2H, CH2), 7.19–8.02 (m, 8H, Ar-H);
IR (KBr): 1699 (C¼¼O), 1540, 1339, 1112 cmꢀ1; MS (70 eV)
m/z (%): 324 (Mþ, 96), 295 (46), 185 (68), 158 (100), 130
(20), 102 (70), 95 (10); Anal. Calcd for C18H13FN2O3 (324.3):
C, 66.66; H, 4.04; N, 8.64. Found: C, 66.71; H, 4.10; N, 8.60.
General procedure for the preparation of 2-alkylamino-
benzofuro [3,2-d] pyrimidin-4(3H)-ones 7a–7c. To the solu-
tion of carbodiimide 3 (ca. 2 mmol) prepared above in methyl-
ene chloride (15 mL) was added alkylamine (2 mmol). After
the reaction mixture was allowed to stand for 0.5–2 h, the so-
lution was condensed and anhydrous ethanol (10 mL) with
several drops of EtOꢀNaþ in EtOH was added. The mixture
was stirred for 1–4 h at room temperature. The solution was
concentrated under reduced pressure and the residual was
recrystallized from ethanol and dichloromethane (v/v ¼ 1:2) at
room temperature to give 2-alkylamino-benzofuro [3,2-d] pyri-
midin-4(3H)-ones 7a–7c.
General procedure for the preparation of 2-aroxy-3-(4-
fluorophenyl)-benzofuro [3,2-d] pyrimidin-4(3H)-ones 5e–
5g. To the solution of carbodiimide 3 (ca. 2 mmol) prepared
above in CH3CN (15 mL) was added K2CO3 (0.2 mmol) and
ArOH (2 mmol) in anhydrous CH3CN (10 mL). The mixture
was stirred for 6–8 h at 50–60ꢁC. The solution was concen-
trated under reduced pressure and the residue was recrystal-
lized from dichloromethane and ethanol (v/v ¼ 2:1) at room
temperature to give 5e–5g.
2-(3,4-Dimethylphenoxy)-3-(4-fluro-phenyl)-benzofuro [3,2-
d] pyrimidin-4(3H)-one (5e). White crystals (87% yields),
Mp: 172–173ꢁC. 1H NMR (400 MHz, CDCl3) d ¼ 2.25 (s,
6H, 2 ꢂ CH3), 6.91–7.84 (m, 11H, Ar-H); 13C NMR (CDCl3,
100 MHz) d ¼ 19.1, 19.8, 112.7, 116.4, 116.6, 118.2, 121.7
(1), 122.3, 123.5, 129.5, 129.8 (2), 130.2, 130.5, 134.3, 135.5,
138.0, 142.0, 149.7, 153.6, 157.2, 161.4, 163.8; IR (KBr):
1698 (C¼¼O), 1536, 1332, 1112 cmꢀ1; MS (70 eV) m/z (%):
400 (47), 262 (100),130 (30),102 (16), 95 (6); Anal. Calcd for
C19H16FN3O2 (400.4): C, 71.99; H, 4.28; N, 7.00. Found: C,
72.05; H, 4.34; N, 6.96.
2-(4-Chloro-2-methyl-phenoxy)-3-(4-fluro-phenyl)-benzofuro
[3,2-d] pyrimidin-4(3H)-one (5f). White crystals (81% yield),
Mp: 241–242ꢁC. 1H NMR (400 MHz, CDCl3) d ¼ 2.18 (s,
3H, Ar-CH3), 7.16–7.82 (m, 13H, Ar-H); 13C NMR (CDCl3,
100 MHz) d ¼ 16.5, 112.8, 116.8, 121.8, 122.2, 123.7, 127.5,
127.7, 129.4, 129.8, 130.2, 131.6, 134.1, 135.7, 142.0, 145.1,
151.5, 153.4, 157.3, 161.6, 164.1. IR (KBr): 1701 (C¼¼O),
1543, 1328, 1098 cmꢀ1; MS (70 eV) m/z (%): 420 (Mþ, 22),
282 (100), 130 (21), 95 (4); Anal. Calcd for C23H14ClFN2O3
(420.1): C, 65.64; H, 3.35; N, 6.66. Found: C, 65.61; H, 3.37;
N, 6.59.
3-(4-Fluorophenyl)-2-(n-propylamino)-benzofuro
[3,2-d]
pyrimidin-4(3H)-one (7a). White crystals (yield: 0.56 g, 83%),
Mp: 199–200ꢁC; 1H NMR (400 MHz, CDCl3) d ¼ 0.87 (t, J
¼ 7.2 Hz, 3H, CH3), 1.54–1.60 (m, 2H, CH2), 3.42–3.47 (m,
2H, NCH2), 4.11 (s, 1H, NH), 7.30–8.02 (m, 8H, Ar-H); IR
(KBr): 3341 (NAH), 1699 (C¼¼O), 1540, 1342, 1111 cmꢀ1
;
MS (70 eV) m/z (%): 337 (Mþ, 32), 294 (100), 185 (35), 160
(64), 130 (71), 102 (82), 95 (53); Anal. Calcd for
C19H16FN3O2 (337.4): C, 67.65; H, 4.78; N, 12.46. Found: C,
67.71; H, 4.84; N, 12.37.
3-(4-Fluorophenyl)-2-(n-butylamino)-benzofuro [3,2-d] pyr-
imidin-4(3H)-one (7b). White crystals (yield: 0.56 g, 79%),
Mp: 191–192ꢁC. 1H NMR (400 MHz, CDCl3) d ¼ 0.89 (t, J
¼ 7.2 Hz, 3H, CH3), 1.25–1.54 (m, 4H, 2 ꢂ CH2), 3.43–3.47
(m, 2H, NCH2), 4.14 (s, 1H, NH), 7.29–8.01 (m, 8H, Ar-H);
13C NMR (CDCl3, 100 MHz) d ¼ 13.6, 19.8, 31.0, 41.8,
112.6, 117.6 (2), 121.5, 122.9, 123.0, 129.2, 130.8 (1), 132.9,
144.6, 151.8, 153.6, 157.2, 161.7,164.2. IR (KBr): 3336
(NAH), 1704 (C¼¼O), 1533, 1340, 1115 cmꢀ1; MS (70 eV) m/
z (%): 351 (Mþ, 78), 334 (41),308 (35), 294 (100), 185 (48),
130 (70),102 (82), 95 (52); Anal. Calcd for C20H18FN3O2
(351.4): C, 68.36; H, 5.16; N, 11.96. Found: C, 68.33; H,
5.20; N, 11.89.
2-(4-Methyl-phenoxy)-3-(4-fluro-phenyl)-benzofuro [3,2-d]
pyrimidin-4(3H)-one (5g). White crystals (88% yield), Mp:
1
170–172ꢁC. H NMR (400 MHz, CDCl3) d ¼ 2.37 (s, 3H, Ar-
CH3), 7.04–7.86 (m, 13H, Ar-H); 13C NMR (CDCl3, 100
MHz) d ¼ 20.8, 112.8, 116.4, 116.7, 120.9, 121.3, 122.9,
123.2, 129.6, 129.8 (2), 130.5, 135.5, 135.7, 142.0, 149.6,
153.5, 157.3, 161.4, 163.9. IR (KBr): 1705 (C¼¼O), 1539,
1346, 1108 cmꢀ1; MS (70 eV) m/z (%): 386 (Mþ, 44), 249
(100), 130 (27), 95 (6); Anal. Calcd for C23H15FN2O3 (386.4):
C, 71.50; H, 3.91; N, 7.25. Found: C, 71.42; H, 3.88; N, 7.19.
General procedure for the preparation of 2-alkoxy-3-(4-
fluorophenyl)-benzofuro [3,2-d] pyrimidin-4(3H)-ones 5h–
5i. To the solution of carbodiimide 3 (ca. 2 mmol) prepared
above in anhydrous ROH (8 mL) was added ROꢀNaþ (0.2
mmol, 10% equiv) in ROH. The mixture was stirred for 4–6 h
at room temperature. The solution was condensed and the resi-
due was recrystallized from ROH to give 5h–5i.
2-(Cyclohexylamino)-3-(4-fluorophenyl)-benzofuro [3,2-d]
pyrimidin-4(3H)-one (7c) White crystals (yield: 0.66 g, 88%),
1
Mp: 188–190ꢁC. H NMR (400 MHz, CDCl3) d ¼ 1.05–1.42
(m, 6H, 3 ꢂ CH2), 1.60–1.62 (m, 4H, 2 ꢂ CH2), 1.96–1.99
(m, 1H, CH), 4.02–4.05 (m, 1H, NH), 7.19–8.04 (m, 9H, Ar-
H); IR (KBr): 1704 (C¼¼O), 1533, 1340, 1115 cmꢀ1; MS (70
eV) m/z (%): 377 (Mþ, 22), 294 (100), 185 (20), 130 (29),102
(30), 98 (27), 55 (26); Anal. Calcd for C22H20FN3O2 (377.4):
C, 70.01; H, 5.34; N, 11.13. Found: C, 69.97; H, 5.37; N,
11.08.
2-Methoxy-3-(4-florophenyl)-benzofuro [3,2-d] pyrimidin-
4(3H)-one (5h). White crystals (yield: 0.54 g, 87%), Mp: 236–
237ꢁC. 1H NMR (400 MHz, CDCl3) d ¼ 4.04 (s, 3H, CH3),
7.19–8.03 (m, 8H, Ar-H); IR (KBr): 1701 (C¼¼O), 1541, 1340,
1108 cmꢀ1; MS (70 eV) m/z (%): 310 (100), 136 (33), 130
(47), 108 (98), 102 (68), 95 (28), 75 (16); Anal. Calcd for
C19H16FN3O2 (310.3): C, 65.81; H, 3.57; N, 9.03. Found: C,
65.87; H, 3.62; N, 8.98.
Fungicidal testing. F. oxysporium, R. solani, B. cinereap-
ers, G. zeae, D. gregaria, and C. gossypii were provided
through the courtesy of the Center for bioassay, Central China
Normal University. The tested samples were dissolved in 0.5
mL of DMF, added to a drop of emulsifying agent (Tween 80)
and sterile water at a concentration of 500 mg/L. The solutions
(1 mL) were mixed rapidly with thawed potato glucose agar
culture medium (9 mL) under 50ꢁC. The mixtures were poured
into Petri dishes. After the dishes were cooled, the solidified
plates were incubated with 4 mm mycelium disk, inverted, and
incubated at 28ꢁC for 48 h. The mixed medium without
2-Ethoxy-3-(4-florophenyl)-benzofuro [3,2-d] pyrimidin-
4(3H)-one (5i). White crystals (yield: 0.56 g, 89%), Mp: 202–
1
204ꢁC. H NMR (400 MHz, CDCl3) d ¼ 1.28 (t, J ¼ 7.2, 3H,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet